This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss
For any queries, please contact Customer Services or your Account Manager. Dismiss
News & Analysis (228)
-
December 03, 2025 | Insight IP stakeholders split on potential impact of US PTAB rulemaking
...Trial and Appeal Board institutes inter partes review (IPR) petitions....
Sections: Intellectual Property
-
December 02, 2025 | Insight Seagen antibody-drug conjugate patent suffers dual defeats on appeal in US
...Trial and Appeal Board in post-grant review proceedings that claims 1–5, 9, and 10 of the ‘039 patent...
Sections: Intellectual Property
-
December 01, 2025 | Comment USPTO's stance on AI inventorship clears up lingering confusion, uncertainty
...Trial and Appeal Board judge Kit Crumbley, now a partner at Bracewell....
Sections: Artificial Intelligence and Intellectual Property
Get the inside track, with MLex
With a global network of expert journalists digging deep into the areas of risk that matter to your business and clients—and the highest standards of impartiality—you can have complete trust in MLex to keep you ahead of the regulatory curve.
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from specialists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
TRY MLEX FREE FOR 14 DAYS
View full search results
Already a subscriber? Click here to login